✦ LIBER ✦

Angiogenesis in hematologic malignancies

✍ Scribed by T. Moehler; K. Neben; A. Ho; H. Goldschmidt

Publisher: Springer
Year: 2001
Tongue: English
Weight: 251 KB
Volume: 80
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-001-0398-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Angiogenesis in Hematologic Malignancies

Angiogenesis in Hematologic Malignancies and Its Clinical Implications

✍ Renchi Yang; Zhong Chao Han 📂 Article 📅 2002 🏛 Carden Jennings Publishing 🌐 English ⚖ 119 KB

Cytogenetic polyclonality in hematologic

Cytogenetic polyclonality in hematologic malignancies

✍ Bertil Johansson; Rolf Billström; Karin Broberg; Thoas Fioretos; Per-Gunnar Nils 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 1 views

The present study was undertaken to ascertain the frequency of cytogenetic polyclonality in various hematologic malignancies and to investigate whether morphologic subgroup, age, gender, or previous genotoxic exposure influences the incidence. Among 2,243 cytogenetically investigated hematologic mal

Pregnancy outcome in hematologic maligna

Pregnancy outcome in hematologic malignancies

✍ Javier Zuazu; Antonio Julia; Jorge Sierra; M. Gl. Valentin; A. Coma; Miguel A. S 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 658 KB

Serum ferritin in hematologic malignanci

Serum ferritin in hematologic malignancies

✍ Y. Matzner; A. M. Konijn; C. Hershko 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 491 KB 👁 1 views

AKT/NF-κB inhibitor xanthohumol targets

AKT/NF-κB inhibitor xanthohumol targets cell growth and angiogenesis in hematologic malignancies

✍ Raffaella Dell'Eva; Claudia Ambrosini; Nicola Vannini; Giovanna Piaggio; Adriana 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB

## Abstract ## BACKGROUND. Leukemias are dependent on Akt/NF‐κB activation and angiogenesis. ## METHODS. The antiangiogenic Akt/NF‐κB inhibitor xanthohumol (XN) has in vitro activity against acute and chronic myelogenous leukemia cell lines (AML, CML) and fresh samples from patients were investi

TRAIL/TRAIL-R in hematologic malignancie

TRAIL/TRAIL-R in hematologic malignancies

✍ Ugo Testa 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

## Abstract Defects in apoptosis are observed in many cancer cell types and contribute in a relevant way to tumorigenesis. Apoptosis is a complex and well‐regulated cell death program that plays a key role in the control of cell homeostasis, particularly at the level of the hematopoietic system. Ap